18000 doses a day in anz, page-103

Do the math on that and the revenue whilst not be sneezed at, does not come anywhere near to producing 10 - 20c of shareholder value in the short to medium term. The real juice of course is if they can get a global distribution agreement going, then you might be talking some real money.

Yes it does, its easily worth 12c for Aus/NZ markets alone. We're asking ourselves if commercialisation and mass take up, could it be worth a $90mill marketcap for POH? In other words, using a very, very conservative PE of 10, could it be worth a profit of $9mill per year for POH? Of course it can.

This is before any global distribution. With this one, there is very little barrier. It's a far superior solution to anythign available and it is very different to trying to get your name out there amongst a myriad of cosmetic products for example.